18Fluorodeoxyglucose Positron Emission Tomography to Detect Mediastinal or Internal Mammary Metastases in Breast Cancer
- 1 August 2001
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 19 (15) , 3516-3523
- https://doi.org/10.1200/jco.2001.19.15.3516
Abstract
PURPOSE: To determine the prevalence of suspected disease in the mediastinum and internal mammary (IM) node chain by 18fluorodeoxyglucose (FDG) positron emission tomography (PET), compared with con...Keywords
This publication has 35 references indexed in Scilit:
- Should internal mammary nodes be sampled in the sentinel lymph node era?Annals of Surgical Oncology, 2000
- Axillary lymph node metastases: screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET.Radiology, 1997
- Regional nodal management and patterns of failure following conservative surgery and radiation therapy for stage I and II breast cancerInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Risk of internal mammary lymph node metastases and its prognostic value in breast cancer patientsJournal of Surgical Oncology, 1993
- Post-mastectomy radiotherapy following adjuvant chemotherapy and autologous bone marrow transplantation for breast cancer patients with ≥ 10 positive axillary lymph nodesInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer?Cancer, 1990
- Prognosis of Breast Cancer Patients after Mastectomy and Dissection of Internal Mammary NodesAnnals of Surgery, 1985
- Inefficacy of internal mammary nodes dissection in breast cancer surgeryCancer, 1981
- The influence of untreated internal mammary metastases upon the course of mammary cancerCancer, 1977
- Radical mastectomy versus radical mastectomy plus internal mammary dissection. Five-year results of an international cooperative studyCancer, 1976